Acadia Pharmaceuticals
ACAD • NASDAQ • Stock Fundamentals
Acadia Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Catherine E. Owen Adams, with a market cap of $3.7B.
Market Cap$3.7B
Employees610.0
CEOCatherine E. Owen Adams
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Acadia Pharmaceuticals FAQ
Common questions about Acadia Pharmaceuticals
Acadia Pharmaceuticals (ACAD) has a market capitalization of $3.7B and trades on NASDAQ.
Acadia Pharmaceuticals has approximately 610 employees.